Oncolytic Virus Therapy Market Report 2026
Download Free Sample Buy Now
Oncolytic Virus Therapy Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Oncolytic Virus Therapy Market Report 2026

Global Outlook – By Therapy Type (Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, Newcastle Disease Virus (NDV), Other Therapy Types), By Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), By Application (Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer), By End-User (Hospitals, Specialty Clinics, Cancer Research Institutes) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Oncolytic Virus Therapy Market Overview

• Oncolytic Virus Therapy market size has reached to $0.23 billion in 2025

• Expected to grow to $0.68 billion in 2030 at a compound annual growth rate (CAGR) of 23.7%

• Growth Driver: Rising Cancer Prevalence Drives Growth In The Oncolytic Virus Therapy Market

• Market Trend: Accelerating Oncolytic Virus Therapy Development Through Regulatory Approvals

• North America was the largest region and fastest growing region.

What Is Covered Under Oncolytic Virus Therapy Market?

Oncolytic virus therapy, also known as virotherapy, is a type of cancer treatment that utilizes viruses to target and destroy cancer cells in the body. The main objective of oncolytic virus therapy is to use viruses that have been genetically modified or naturally occur in a way that allows them to selectively infect and replicate within cancer cells while sparing healthy cells.

The main types of oncolytic virus therapy are HSV-based oncolytic virus therapy, adenovirus-based oncolytic virus therapy, reovirus, poxviruses, Newcastle disease virus (NDV), and others. HSV-based oncolytic virus therapy utilizes the herpes simplex virus (HSV) as the platform for treatment. The various virus types include genetically engineered oncolytic viruses and oncolytic wild-type viruses. These are used in various applications such as breast cancer, lung cancer, prostate cancer, melanoma, brain tumor, and blood cancer and are also used by end-users such as hospitals, specialty clinics, and cancer research institutes.

Oncolytic Virus Therapy Market Global Report 2026 Market Report bar graph

What Is The Oncolytic Virus Therapy Market Size and Share 2026?

The oncolytic virus therapy market size has grown exponentially in recent years. It will grow from $0.23 billion in 2025 to $0.29 billion in 2026 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to development of hsv- and adenovirus-based oncolytic therapies, early clinical trials in melanoma and breast cancer, growing interest from cancer research institutes, increasing government funding for virotherapy research, rising collaborations between biotech companies and academic institutions.

What Is The Oncolytic Virus Therapy Market Growth Forecast?

The oncolytic virus therapy market size is expected to see exponential growth in the next few years. It will grow to $0.68 billion in 2030 at a compound annual growth rate (CAGR) of 23.7%. The growth in the forecast period can be attributed to rising demand for genetically engineered oncolytic viruses, increasing adoption in lung, prostate, and brain cancers, growth of specialty clinics and hospitals offering virotherapy, rising investment in combination and emerging virus therapies, expansion of clinical trial infrastructure in emerging markets. Major trends in the forecast period include rising adoption of ai and big data in oncolytic virus research, increasing use of genomics and precision medicine for therapy design, growing implementation of digital platforms for clinical trial monitoring, rising automation in virus production and quality assurance, increasing iot-based monitoring of virus storage and distribution.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Oncolytic Virus Therapy Market Segmentation

1) By Therapy Type: Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, Newcastle Disease Virus (NDV), Other Therapy Types

2) By Virus Type: Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses

3) By Application: Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer

4) By End-User: Hospitals, Specialty Clinics, Cancer Research Institutes

Subsegments:

1) By Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy: Genetically Modified Herpes Simplex Virus Oncolytic Viruses, T-VEC (Talimogene Laherparepvec) Therapy, Herpes Simplex Virus-Based Combination Therapies, Herpes Simplex Virus-Based Targeted Oncolytic Approaches

2) By Adenovirus-Based Oncolytic Virus Therapy: Conditionally Replicating Adenoviruses, Oncolytic Adenovirus Immunotherapies, Adenovirus-Based Combination Treatments, Targeted Adenovirus Therapies

3) By Reovirus: Reolysin Therapy, Genetically Engineered Reoviruses, Reovirus Combination Treatments, Tumor-Selective Reovirus Approaches

4) By Poxviruses: Vaccinia Virus-Based Oncolytic Therapies, Modified Vaccinia Ankara (MVA) Therapies, Poxvirus Combination Treatments, Tumor-Targeted Poxvirus Therapies

5) By Newcastle Disease Virus (NDV): Wild-Type Newcastle Disease Virus Therapies, Genetically Modified Newcastle Disease Virus Oncolytic Approaches, Newcastle Disease Virus Combination Therapies, Tumor-Selective Newcastle Disease Virus Treatments

6) By Other Therapy Types: Measles Virus-Based Oncolytic Therapies, Vesicular Stomatitis Virus (VSV) Therapies, Other Experimental Oncolytic Virus Treatments, Emerging Oncolytic Virus Platforms

What Is The Driver Of The Oncolytic Virus Therapy Market?

The increasing prevalence of cancer cases is expected to propel the growth of the oncolytic virus therapy market going forward. Cancer is a term used to describe a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. Oncolytic virus therapy offers the potential to selectively target and destroy cancer cells while stimulating an immune response against the tumor, providing a dual mechanism of action for effective cancer treatment. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of cancer cases is driving the growth of the oncolytic virus therapy industry.

Key Players In The Global Oncolytic Virus Therapy Market

Major companies operating in the oncolytic virus therapy market are Sorrento Therapeutics Inc., Amgen Inc., Takara Bio Inc., Oncorus Inc., Replimune Inc., Vyriad Inc., Genelux Corporation, Oncolys BioPharma Inc., Oncolytics Biotech Inc., TILT Biotherapeutics Ltd., Transgene SA, Provectus Biopharmaceuticals Inc., Vibalogics, Turnstone Biologics, PsiOxus Therapeutics Ltd., Targovax, Cold Genesys, Shanghai Sunway Biotech Co Ltd., Neotropix, Candel Therapeutics Inc., CG Oncology, DNAtrix Inc., Oryx GmbH, ViroCure, GeneMedicine, VCN Biosciences, Beijing Syngentech, KaliVir Immunotherapeutics Inc.

Global Oncolytic Virus Therapy Market Trends and Insights

Major companies operating in the oncolytic virus therapy market are concentrating on obtaining regulatory approvals to expedite the introduction of innovative therapies for cancer treatment. Regulatory approvals refer to the process by which health authorities evaluate and authorize medical products, including drugs, biologics, and medical devices, for use in the market. For instance, in March 2024, ImmVira, a China-based biotechnology company, received Fast Track designation from the FDA for its oncolytic virus therapy, MVR-T3011 IT, aimed at treating recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) in patients who have experienced disease progression after platinum-based chemotherapy and at least one prior line of anti-PD-1/PD-L1 therapy. This designation is intended to expedite the development and review process for therapies addressing serious conditions with unmet medical needs.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Oncolytic Virus Therapy Market?

In February 2025, UroGen Pharma Ltd., a US-Israel-based biotechnology company, acquired assets related to the oncolytic virus ICVB-1042 from IconOVir Bio, Inc., for an undisclosed amount. Through this acquisition, UroGen aims to expand its oncolytic virus therapy pipeline and strengthen its technological capabilities in immunotherapy, particularly for bladder cancer and other locally treated malignancies. IconOVir Bio is a US-based developer of next-generation oncolytic viruses, including ICVB 1042, designed to selectively kill cancer cells and trigger immune responses.

Regional Outlook

North America was the largest region in the oncolytic virus therapy market in 2025 and is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oncolytic Virus Therapy Market?

The oncolytic virus therapy market includes revenues earned by entities by providing seneca valley virus (SVV), semliki forest virus (SFV), vesicular stomatitis virus (VSV), and sindbis virus (SBV). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oncolytic Virus Therapy Market Report 2026?

The oncolytic virus therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oncolytic virus therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Oncolytic Virus Therapy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $0.29 billion
Revenue Forecast In 2035 $0.68 billion
Growth Rate CAGR of 23.7% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Therapy Type, Virus Type, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Sorrento Therapeutics Inc., Amgen Inc., Takara Bio Inc., Oncorus Inc., Replimune Inc., Vyriad Inc., Genelux Corporation, Oncolys BioPharma Inc., Oncolytics Biotech Inc., TILT Biotherapeutics Ltd., Transgene SA, Provectus Biopharmaceuticals Inc., Vibalogics, Turnstone Biologics, PsiOxus Therapeutics Ltd., Targovax, Cold Genesys, Shanghai Sunway Biotech Co Ltd., Neotropix, Candel Therapeutics Inc., CG Oncology, DNAtrix Inc., Oryx GmbH, ViroCure, GeneMedicine, VCN Biosciences, Beijing Syngentech, KaliVir Immunotherapeutics Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Oncolytic Virus Therapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Oncolytic Virus Therapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Oncolytic Virus Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Oncolytic Virus Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Digitalization, Cloud, Big Data & Cybersecurity

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Biotechnology, Genomics & Precision Medicine

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Rising Adoption Of Ai And Big Data In Oncolytic Virus Research

4.2.2 Increasing Use Of Genomics And Precision Medicine For Therapy Design

4.2.3 Growing Implementation Of Digital Platforms For Clinical Trial Monitoring

4.2.4 Rising Automation In Virus Production And Quality Assurance

4.2.5 Increasing Iot-Based Monitoring Of Virus Storage And Distribution

5. Oncolytic Virus Therapy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Cancer Research Institutes

5.4 Biotechnology Companies

5.5 Academic And Research Institutes

6. Oncolytic Virus Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oncolytic Virus Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Oncolytic Virus Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Oncolytic Virus Therapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Oncolytic Virus Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Oncolytic Virus Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oncolytic Virus Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oncolytic Virus Therapy Market Segmentation

9.1. Global Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, Newcastle Disease Virus (NDV), Other Therapy Types

9.2. Global Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses

9.3. Global Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer

9.4. Global Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Cancer Research Institutes

9.5. Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genetically Modified Herpes Simplex Virus Oncolytic Viruses, T-VEC (Talimogene Laherparepvec) Therapy, Herpes Simplex Virus-Based Combination Therapies, Herpes Simplex Virus-Based Targeted Oncolytic Approaches

9.6. Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Adenovirus-Based Oncolytic Virus Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Conditionally Replicating Adenoviruses, Oncolytic Adenovirus Immunotherapies, Adenovirus-Based Combination Treatments, Targeted Adenovirus Therapies

9.7. Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Reovirus, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Reolysin Therapy, Genetically Engineered Reoviruses, Reovirus Combination Treatments, Tumor-Selective Reovirus Approaches

9.8. Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Poxviruses, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vaccinia Virus-Based Oncolytic Therapies, Modified Vaccinia Ankara (MVA) Therapies, Poxvirus Combination Treatments, Tumor-Targeted Poxvirus Therapies

9.9. Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Newcastle Disease Virus (NDV), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Wild-Type Newcastle Disease Virus Therapies, Genetically Modified Newcastle Disease Virus Oncolytic Approaches, Newcastle Disease Virus Combination Therapies, Tumor-Selective Newcastle Disease Virus Treatments

9.10. Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Measles Virus-Based Oncolytic Therapies, Vesicular Stomatitis Virus (VSV) Therapies, Other Experimental Oncolytic Virus Treatments, Emerging Oncolytic Virus Platforms

10. Oncolytic Virus Therapy Market Regional And Country Analysis

10.1. Global Oncolytic Virus Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Oncolytic Virus Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oncolytic Virus Therapy Market

11.1. Asia-Pacific Oncolytic Virus Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oncolytic Virus Therapy Market

12.1. China Oncolytic Virus Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oncolytic Virus Therapy Market

13.1. India Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oncolytic Virus Therapy Market

14.1. Japan Oncolytic Virus Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oncolytic Virus Therapy Market

15.1. Australia Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oncolytic Virus Therapy Market

16.1. Indonesia Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oncolytic Virus Therapy Market

17.1. South Korea Oncolytic Virus Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Oncolytic Virus Therapy Market

18.1. Taiwan Oncolytic Virus Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Oncolytic Virus Therapy Market

19.1. South East Asia Oncolytic Virus Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Oncolytic Virus Therapy Market

20.1. Western Europe Oncolytic Virus Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Oncolytic Virus Therapy Market

21.1. UK Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Oncolytic Virus Therapy Market

22.1. Germany Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Oncolytic Virus Therapy Market

23.1. France Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Oncolytic Virus Therapy Market

24.1. Italy Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Oncolytic Virus Therapy Market

25.1. Spain Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Oncolytic Virus Therapy Market

26.1. Eastern Europe Oncolytic Virus Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Oncolytic Virus Therapy Market

27.1. Russia Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Oncolytic Virus Therapy Market

28.1. North America Oncolytic Virus Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Oncolytic Virus Therapy Market

29.1. USA Oncolytic Virus Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Oncolytic Virus Therapy Market

30.1. Canada Oncolytic Virus Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Oncolytic Virus Therapy Market

31.1. South America Oncolytic Virus Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Oncolytic Virus Therapy Market

32.1. Brazil Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Oncolytic Virus Therapy Market

33.1. Middle East Oncolytic Virus Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Oncolytic Virus Therapy Market

34.1. Africa Oncolytic Virus Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Segmentation By Virus Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Oncolytic Virus Therapy Market Regulatory and Investment Landscape

36. Oncolytic Virus Therapy Market Competitive Landscape And Company Profiles

36.1. Oncolytic Virus Therapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Oncolytic Virus Therapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Oncolytic Virus Therapy Market Company Profiles

36.3.1. Sorrento Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Takara Bio Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Oncorus Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Replimune Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Oncolytic Virus Therapy Market Other Major And Innovative Companies

Vyriad Inc., Genelux Corporation, Oncolys BioPharma Inc., Oncolytics Biotech Inc., TILT Biotherapeutics Ltd., Transgene SA, Provectus Biopharmaceuticals Inc., Vibalogics, Turnstone Biologics, PsiOxus Therapeutics Ltd., Targovax, Cold Genesys, Shanghai Sunway Biotech Co Ltd., Neotropix, Candel Therapeutics Inc.

38. Global Oncolytic Virus Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Oncolytic Virus Therapy Market

40. Oncolytic Virus Therapy Market High Potential Countries, Segments and Strategies

40.1 Oncolytic Virus Therapy Market In 2030 - Countries Offering Most New Opportunities

40.2 Oncolytic Virus Therapy Market In 2030 - Segments Offering Most New Opportunities

40.3 Oncolytic Virus Therapy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Oncolytic Virus Therapy Market, Overview Of Key Products - Product Examples
  • Table 2: Global Oncolytic Virus Therapy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Oncolytic Virus Therapy Market, Supply Chain Analysis
  • Table 4: Global Oncolytic Virus Therapy Market, Major Raw Material Providers
  • Table 5: Global Oncolytic Virus Therapy Market, Major Resource Providers
  • Table 6: Global Oncolytic Virus Therapy Market, Major Manufacturers (Suppliers)
  • Table 7: Global Oncolytic Virus Therapy Market, Major Distributors And Channel Partners
  • Table 8: Global Oncolytic Virus Therapy Market, Key Technologies & Future Trends
  • Table 9: Global Oncolytic Virus Therapy Market, Major Trends
  • Table 10: Global Oncolytic Virus Therapy Market, Major End Users
  • Table 11: Global Oncolytic Virus Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Oncolytic Virus Therapy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Oncolytic Virus Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Oncolytic Virus Therapy Market - TAM, US$ Billion, 2025
  • Table 15: Global Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Adenovirus-Based Oncolytic Virus Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Reovirus, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Poxviruses, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Newcastle Disease Virus (NDV), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Oncolytic Virus Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Oncolytic Virus Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Global Oncolytic Virus Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 100: Global Oncolytic Virus Therapy Market - Company Scoring Matrix
  • Table 101: Sorrento Therapeutics Inc. Financial Performance
  • Table 102: Amgen Inc. Financial Performance
  • Table 103: Takara Bio Inc. Financial Performance
  • Table 104: Oncorus Inc. Financial Performance
  • Table 105: Replimune Inc. Financial Performance
  • Table 106: Global Oncolytic Virus Therapy Market, Competitive Benchmarking (In USD Billions)
  • Table 107: Global Oncolytic Virus Therapy Market, Competitive Dashboard
  • Table 108: Global Oncolytic Virus Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 109: Global, Oncolytic Virus Therapy Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030
  • Table 110: Global, Oncolytic Virus Therapy Market Size Gain ($ Billion), Segmentation By Virus Type, 2025 – 2030
  • Table 111: Global, Oncolytic Virus Therapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Oncolytic Virus Therapy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Oncolytic Virus Therapy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Oncolytic Virus Therapy Market, Supply Chain Analysis
  • Figure 4: Global Oncolytic Virus Therapy Market, Major Raw Material Providers
  • Figure 5: Global Oncolytic Virus Therapy Market, Major Resource Providers
  • Figure 6: Global Oncolytic Virus Therapy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Oncolytic Virus Therapy Market, Major Distributors And Channel Partners
  • Figure 8: Global Oncolytic Virus Therapy Market, Key Technologies & Future Trends
  • Figure 9: Global Oncolytic Virus Therapy Market, Major Trends
  • Figure 10: Global Oncolytic Virus Therapy Market, Major End Users
  • Figure 11: Global Oncolytic Virus Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Oncolytic Virus Therapy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Oncolytic Virus Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Oncolytic Virus Therapy Market - TAM, US$ Billion, 2025
  • Figure 15: Global Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Adenovirus-Based Oncolytic Virus Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Reovirus, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Poxviruses, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Newcastle Disease Virus (NDV), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Oncolytic Virus Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Oncolytic Virus Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Oncolytic Virus Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Global Oncolytic Virus Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 100: Global Oncolytic Virus Therapy Market - Company Scoring Matrix
  • Figure 101: Sorrento Therapeutics Inc. Financial Performance
  • Figure 102: Amgen Inc. Financial Performance
  • Figure 103: Takara Bio Inc. Financial Performance
  • Figure 104: Oncorus Inc. Financial Performance
  • Figure 105: Replimune Inc. Financial Performance
  • Figure 106: Global Oncolytic Virus Therapy Market, Competitive Benchmarking (In USD Billions)
  • Figure 107: Global Oncolytic Virus Therapy Market, Competitive Dashboard
  • Figure 108: Global Oncolytic Virus Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 109: Global, Oncolytic Virus Therapy Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030
  • Figure 110: Global, Oncolytic Virus Therapy Market Size Gain ($ Billion), Segmentation By Virus Type, 2025 – 2030
  • Figure 111: Global, Oncolytic Virus Therapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

AL Amyloidosis Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Read More About AL Amyloidosis Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Anemia In Elderly Market Trends: Regional Breakdowns and Strategic Insights

Read More About Global Anemia In Elderly Market Trends: Regional Breakdowns and Strategic Insights

Artificial Intelligence (AI) In Aging And Elderly Care Outlook 2034: Key Drivers, Trends, and Market Frontiers

Read More About Artificial Intelligence (AI) In Aging And Elderly Care Outlook 2034: Key Drivers, Trends, and Market Frontiers

Artificial Intelligence-Powered Solutions For Elderly CareMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

Read More About Artificial Intelligence-Powered Solutions For Elderly CareMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Oncolytic Virus Therapy Market Report 2026 - Global Outlook – By Therapy Type (Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, Newcastle Disease V...

Antiviral Combination Therapy Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Combination (Nucleotide Reverse Transcriptase Inhibitors/Non-Nucleotide Reverse Transcriptase Inhibitors, Integrase ...

Antivirals Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes )...

Infectious Disease Therapeutics Market Report 2026 - Global Outlook – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharm...

COVID-19 Current Therapy Market Report 2026 - Global Outlook – By Drug Type (Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs...

Viral Inactivation Market Report 2026 - Global Outlook – By Product (Kits And Reagents, Systems, Services), By Method (Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods), By Application (Vacci...

Herpes Simplex Virus Treatment Market Report 2026 - Global Outlook – By Type (Herpes Simplex Virus-1 Infection, Herpes Simplex Virus-2 Infection), By Drug Type (Acyclovir, Valacyclovir, Famciclovir, Other Drugs), By Rout...

Therapeutic BCG Vaccines Market Report 2026 - Global Outlook – By Type (Therapy BCG, Other Types), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global ...

Frequently Asked Questions

The Oncolytic Virus Therapy market was valued at $0.23 billion in 2025, increased to $0.29 billion in 2026, and is projected to reach $0.68 billion by 2030.

The global Oncolytic Virus Therapy market is expected to grow at a CAGR of 23.7% from 2026 to 2035 to reach $0.68 billion by 2035.

Some Key Players in the Oncolytic Virus Therapy market Include, Sorrento Therapeutics Inc., Amgen Inc., Takara Bio Inc., Oncorus Inc., Replimune Inc., Vyriad Inc., Genelux Corporation, Oncolys BioPharma Inc., Oncolytics Biotech Inc., TILT Biotherapeutics Ltd., Transgene SA, Provectus Biopharmaceuticals Inc., Vibalogics, Turnstone Biologics, PsiOxus Therapeutics Ltd., Targovax, Cold Genesys, Shanghai Sunway Biotech Co Ltd., Neotropix, Candel Therapeutics Inc., CG Oncology, DNAtrix Inc., Oryx GmbH, ViroCure, GeneMedicine, VCN Biosciences, Beijing Syngentech, KaliVir Immunotherapeutics Inc. .

Major trend in this market includes: Accelerating Oncolytic Virus Therapy Development Through Regulatory Approvals . For further insights on this market. request a sample here

North America was the largest region in the oncolytic virus therapy market in 2025 and is expected to be the fastest-growing region in the forecast period. The regions covered in the oncolytic virus therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us